Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Aug 2009):

Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.

Full Abstract

OBJECTIVES: Brain-derived neurotrophic factor (BDNF) is an important contributor to the pathophysiology of bipolar disorder (BD), and abnormalities in the BDNF-signaling system may be implicated in the cognitive decline observed in BD patients. We aimed to investigate serum BDNF levels in BD patients and its relation to neurocognitive function. METHODS: We measured serum BDNF levels using an enzyme-linked immunosorbent assay method in 65 euthymic type I BD patients and 50 healthy controls, and administered a neuropsychological test battery to assess attention and mental control, perceptual-motor skills, executive functions, verbal fluency and abstraction, visuospatial attention, and memory. RESULTS: We found no significant differences regarding serum BDNF levels in BD patients and healthy controls. We found significant positive associations between serum BDNF levels and illness duration, and manic and depressive episodes in female BD patients only. Serum BDNF levels were lower in patients medicated with antipsychotics and/or lithium, whereas patients on valproate and/or antidepressants showed higher serum BDNF levels. Patients performed significantly worse on 11 out of 16 neurocognitive tests as compared to controls. We found a significant positive association between serum BDNF levels and a test of verbal fluency in both BD patients and controls. CONCLUSIONS: Present results support the hypothesis that BDNF normalizes with mood stabilization and pharmacological treatment. Our findings in young and physically healthy patients with short illness duration and few mood episodes may explain the lack of association between serum BDNF levels and neurocognitive performance, even though cognitive performance in patients was overall significantly worse as compared to healthy controls.

 

Author information

Author/s: Dias, Vasco Videira (VV); Brissos, Sofia (S); Frey, Benicio N (BN); Andreazza, Ana Cristina (AC); Cardoso, Carlos (C); Kapczinski, Flávio (F);

Affiliation: University of Extremadura (UNEX), Badajoz, Extremadura, Spain.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Bipolar disorders (Bipolar Disord), published in Denmark. (Language: eng)

Reference: 2009-Sep; vol 11 (issue 6) : pp 663-71

Dates: Created 2009/08/19; Completed 2009/11/05;

PMID: 19689509, status: MEDLINE (last retrieval date: 11/5/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Brain-Derived Neurotrophic Factor (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1989
1/30/2008
Higher Relevance Score (100)
Lower Relevance Score (70)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index